oxycodone and aprepitant

oxycodone has been researched along with aprepitant in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Heilig, M; Henderson, P; Lofwall, MR; Nuzzo, PA; Walsh, SL	1
Chayahara, N; Fujiwara, Y; Imamura, Y; Kiyota, N; Minami, H; Mukohara, T; Shimada, T; Toyoda, M	1
Dupuis, LL; Leeder, JS; Patel, P; Piquette-Miller, M	1

Reviews

2 review(s) available for oxycodone and aprepitant

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Aprepitant and fosaprepitant drug interactions: a systematic review. British journal of clinical pharmacology, 2017, Volume: 83, Issue:10 Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Ethanol; Humans; Injection Site Reaction; Morpholines; Nausea; Oxycodone; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Vomiting	2017

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Aprepitant and fosaprepitant drug interactions: a systematic review.

British journal of clinical pharmacology, 2017, Volume: 83, Issue:10

Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Ethanol; Humans; Injection Site Reaction; Morpholines; Nausea; Oxycodone; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Vomiting

2017

Trials

2 trial(s) available for oxycodone and aprepitant

Article	Year
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers. Addiction biology, 2013, Volume: 18, Issue:2 Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Analysis of Variance; Animals; Antiemetics; Aprepitant; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Tolerance; Female; Humans; Male; Mice; Mice, Knockout; Morpholines; Neurokinin-1 Receptor Antagonists; Opioid-Related Disorders; Oxycodone; Placebos; Psychomotor Performance; Receptors, Neurokinin-1; Reinforcement, Psychology; Substance P; Time Factors	2013
Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients. PloS one, 2014, Volume: 9, Issue:8 Topics: Adult; Aged; Analgesics, Opioid; Aprepitant; Area Under Curve; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Morpholines; Neoplasms; Oxycodone; Oxymorphone; Pain	2014

Article

Year

Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.

Addiction biology, 2013, Volume: 18, Issue:2

Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Analysis of Variance; Animals; Antiemetics; Aprepitant; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Tolerance; Female; Humans; Male; Mice; Mice, Knockout; Morpholines; Neurokinin-1 Receptor Antagonists; Opioid-Related Disorders; Oxycodone; Placebos; Psychomotor Performance; Receptors, Neurokinin-1; Reinforcement, Psychology; Substance P; Time Factors

2013

Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients.

PloS one, 2014, Volume: 9, Issue:8

Topics: Adult; Aged; Analgesics, Opioid; Aprepitant; Area Under Curve; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Morpholines; Neoplasms; Oxycodone; Oxymorphone; Pain

2014

Other Studies

1 other study(ies) available for oxycodone and aprepitant

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008